NR Lemoine

451 total citations
11 papers, 353 citations indexed

About

NR Lemoine is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, NR Lemoine has authored 11 papers receiving a total of 353 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Genetics. Recurrent topics in NR Lemoine's work include Cancer Research and Treatments (3 papers), Cancer-related Molecular Pathways (3 papers) and Virus-based gene therapy research (2 papers). NR Lemoine is often cited by papers focused on Cancer Research and Treatments (3 papers), Cancer-related Molecular Pathways (3 papers) and Virus-based gene therapy research (2 papers). NR Lemoine collaborates with scholars based in United Kingdom. NR Lemoine's co-authors include Iain A. McNeish, John P. Neoptolemos, S.M.A. Phillips, C. Ring, Pascale Blouin, David Wynford‐Thomas, G. Melville Williams, Meenu Wadhwa, David Snary and Candace A. Gilbert and has published in prestigious journals such as The Lancet, British Journal of Cancer and Journal of Clinical Pathology.

In The Last Decade

NR Lemoine

11 papers receiving 347 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
NR Lemoine United Kingdom	9	228	129	86	77	59	11	353
Scott F. Winter United States	9	239 1.0×	121 0.9×	84 1.0×	52 0.7×	85 1.4×	10	413
Francesca Ottone Italy	5	137 0.6×	206 1.6×	39 0.5×	29 0.4×	60 1.0×	7	339
Yasuhiro Terazaki Japan	12	182 0.8×	191 1.5×	112 1.3×	53 0.7×	44 0.7×	21	425
Chris Zahn United States	7	120 0.5×	109 0.8×	55 0.6×	43 0.6×	57 1.0×	9	314
Susan K. Rathe United States	12	234 1.0×	100 0.8×	67 0.8×	45 0.6×	84 1.4×	18	390
Tetsuyo ODAJIMA Japan	12	272 1.2×	178 1.4×	58 0.7×	16 0.2×	66 1.1×	32	471
T Toge Japan	8	111 0.5×	140 1.1×	113 1.3×	34 0.4×	37 0.6×	28	321
Meleah Cameron United States	3	141 0.6×	244 1.9×	64 0.7×	31 0.4×	130 2.2×	6	386
Ezequiel J. Tolosa United States	11	221 1.0×	135 1.0×	112 1.3×	29 0.4×	84 1.4×	24	356
Yalei Zhang China	9	178 0.8×	158 1.2×	47 0.5×	73 0.9×	61 1.0×	14	351

Countries citing papers authored by NR Lemoine

Since Specialization

Citations

This map shows the geographic impact of NR Lemoine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by NR Lemoine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites NR Lemoine more than expected).

Fields of papers citing papers by NR Lemoine

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by NR Lemoine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by NR Lemoine. The network helps show where NR Lemoine may publish in the future.

Co-authorship network of co-authors of NR Lemoine

This figure shows the co-authorship network connecting the top 25 collaborators of NR Lemoine. A scholar is included among the top collaborators of NR Lemoine based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with NR Lemoine. NR Lemoine is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

1.

McNeish, Iain A., et al.. (2004). Gene Therapy Progress and Prospects: cancer gene therapy using tumour suppressor genes. Gene Therapy. 11(6). 497–503. 75 indexed citations

2.

Lemoine, NR, et al.. (1998). Biological therapy: approaches in colorectal cancer. British Journal of Cancer. 77(5). 683–693. 18 indexed citations

3.

Ring, C., et al.. (1997). Use of transcriptional regulatory elements of the MUC1 and ERBB2 genes to drive tumour-selective expression of a prodrug activating enzyme. Gene Therapy. 4(10). 1045–1052. 36 indexed citations

4.

Martin, Lisa, Richard G. Vile, NR Lemoine, Karol Sikora, & H. Pandha. (1997). Genetic prodrug activation therapy. The Lancet. 350(9094). 1793–1794. 6 indexed citations

5.

Lemoine, NR, et al.. (1995). Antisense oligonucleotides directed against p53 have antiproliferative effects unrelated to effects on p53 expression. British Journal of Cancer. 71(3). 429–437. 40 indexed citations

6.

Gilbert, Candace A., et al.. (1995). EFFECTS OF ANTISENSE OLIGONUCLEOTIDES TARGETING K-RAS EXPRESSION IN PANCREATIC-CANCER CELL-LINES. International Journal of Oncology. 6(5). 1105–12. 10 indexed citations

7.

Phillips, S.M.A., et al.. (1994). Loss of the retinoblastoma susceptibility gene (RB1) is a frequent and early event in prostatic tumorigenesis. British Journal of Cancer. 70(6). 1252–1257. 116 indexed citations

8.

Klöppel, G., et al.. (1994). LOCALIZATION OF EXPRESSION OF FIBROBLAST GROWTH-FACTORS AND THEIR RECEPTORS IN PANCREATIC ADENOCARCINOMA BY IN-SITU HYBRIDIZATION. International Journal of Oncology. 4(6). 1219–23. 12 indexed citations

9.

Lemoine, NR. (1989). Cell Differentiation, Genes and Cancer. Journal of Clinical Pathology. 42(11). 1231.4–1232. 12 indexed citations

10.

Lemoine, NR, et al.. (1988). Ha-ras restriction fragment length polymorphisms in colorectal cancer. British Journal of Cancer. 57(2). 135–138. 27 indexed citations

11.

Lemoine, NR, et al.. (1986). Immunohistochemical analysis ofmononuclear cell subsets ininflammatory andnon-inflammatory myopathies. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact